Keylika

Keylika is an innovative company focused on addressing the challenges of drug discovery and delivery, particularly in the treatment of iron deficiency anemia (IDA). The company utilizes artificial intelligence to facilitate de novo drug design and employs advanced nanotechnology to develop its therapies. Keylika is working on the world's first prescription skin patch, known as NistuFe, which is designed to treat IDA by allowing direct absorption of a proprietary form of iron into the bloodstream, thereby bypassing the gastrointestinal tract and its associated side effects. This novel approach…